Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor
Clinical trial NCT04346381 · COMPLETED
Trial details
- NCT number
- NCT04346381
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-05
- Primary completion
- 2022-06-22
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.